These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

621 related items for PubMed ID: 15579184

  • 1. Are there disadvantages in administering 131I ablation therapy in patients with differentiated thyroid carcinoma without a preablative diagnostic 131I whole-body scan?
    Salvatori M, Perotti G, Rufini V, Maussier ML, Dottorini M.
    Clin Endocrinol (Oxf); 2004 Dec; 61(6):704-10. PubMed ID: 15579184
    [Abstract] [Full Text] [Related]

  • 2. The value of diagnostic whole-body scanning and serum thyroglobulin in the presence of elevated serum thyrotropin during follow-up of anti-thyroglobulin antibody-positive patients with differentiated thyroid carcinoma who appeared to be free of disease after total thyroidectomy and radioactive iodine ablation.
    Rosario PW, Mineiro Filho AF, Lacerda RX, dos Santos DA, Calsolari MR.
    Thyroid; 2012 Feb; 22(2):113-6. PubMed ID: 22224815
    [Abstract] [Full Text] [Related]

  • 3. Sensitivity of 123I whole-body scan and thyroglobulin in the detection of metastases or recurrent differentiated thyroid cancer.
    de Geus-Oei LF, Oei HY, Hennemann G, Krenning EP.
    Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):768-74. PubMed ID: 12029550
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of the surgical completeness after total thyroidectomy for differentiated thyroid carcinoma.
    Salvatori M, Raffaelli M, Castaldi P, Treglia G, Rufini V, Perotti G, Lombardi CP, Rubello D, Ardito G, Bellantone R.
    Eur J Surg Oncol; 2007 Jun; 33(5):648-54. PubMed ID: 17433606
    [Abstract] [Full Text] [Related]

  • 5. Value of diagnostic radioiodine whole-body scanning after initial therapy in patients with differentiated thyroid cancer at intermediate and high risk for recurrence.
    Rosario PW, Furtado Mde S, Mineiro Filho AF, Lacerda RX, Calsolari MR.
    Thyroid; 2012 Nov; 22(11):1165-9. PubMed ID: 23050784
    [Abstract] [Full Text] [Related]

  • 6. 99mTc-sestamibi and 131I whole-body scintigraphy and initial serum thyroglobulin in the management of differentiated thyroid carcinoma.
    Ng DC, Sundram FX, Sin AE.
    J Nucl Med; 2000 Apr; 41(4):631-5. PubMed ID: 10768563
    [Abstract] [Full Text] [Related]

  • 7. The role of technetium-99m methoxyisobutylisonitrile scintigraphy in the planning of therapy and follow-up of patients with differentiated thyroid carcinoma after surgery.
    Rubello D, Mazzarotto R, Casara D.
    Eur J Nucl Med; 2000 Apr; 27(4):431-40. PubMed ID: 10805117
    [Abstract] [Full Text] [Related]

  • 8. Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma.
    Gallowitsch HJ, Mikosch P, Kresnik E, Unterweger O, Gomez I, Lind P.
    J Nucl Med; 1998 May; 39(5):870-5. PubMed ID: 9591591
    [Abstract] [Full Text] [Related]

  • 9. Is diagnostic iodine-131 scanning with recombinant human TSH useful in the follow-up of differentiated thyroid cancer after thyroid ablation?
    Mazzaferri EL, Kloos RT.
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1490-8. PubMed ID: 11932270
    [Abstract] [Full Text] [Related]

  • 10. Effects of therapeutic doses of 131I in thyroid papillary carcinoma patients with elevated thyroglobulin level and negative 131I whole-body scan: comparative study.
    Koh JM, Kim ES, Ryu JS, Hong SJ, Kim WB, Shong YK.
    Clin Endocrinol (Oxf); 2003 Apr; 58(4):421-7. PubMed ID: 12641624
    [Abstract] [Full Text] [Related]

  • 11. Is stimulation of thyroglobulin (Tg) useful in low-risk patients with thyroid carcinoma and undetectable Tg on thyroxin and negative neck ultrasound?
    Rosário PW, Borges MA, Fagundes TA, Franco AC, Purisch S.
    Clin Endocrinol (Oxf); 2005 Feb; 62(2):121-5. PubMed ID: 15670185
    [Abstract] [Full Text] [Related]

  • 12. Diagnostic 131-iodine whole-body scan may be avoided in thyroid cancer patients who have undetectable stimulated serum Tg levels after initial treatment.
    Pacini F, Capezzone M, Elisei R, Ceccarelli C, Taddei D, Pinchera A.
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1499-501. PubMed ID: 11932271
    [Abstract] [Full Text] [Related]

  • 13. Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid cancer?
    Cailleux AF, Baudin E, Travagli JP, Ricard M, Schlumberger M.
    J Clin Endocrinol Metab; 2000 Jan; 85(1):175-8. PubMed ID: 10634383
    [Abstract] [Full Text] [Related]

  • 14. Management of low-risk patients with thyroid carcinoma and detectable thyroglobulin on T4 after thyroidectomy and ablation with iodine-131.
    Rosário PW, Borges MA, Costa GB, Rezende LL, Padrão EL, Barroso AL, Purisch S.
    Arq Bras Endocrinol Metabol; 2007 Feb; 51(1):99-103. PubMed ID: 17435862
    [Abstract] [Full Text] [Related]

  • 15. Nuclear medicine approaches in the monitoring of thyroid cancer patients.
    Sergieva S, Hadjieva T, Doldurova M, Stefanova S, Dudov A.
    J BUON; 2006 Feb; 11(4):511-8. PubMed ID: 17309186
    [Abstract] [Full Text] [Related]

  • 16. Radioiodine treatment with 30 mCi after recombinant human thyrotropin stimulation in thyroid cancer: effectiveness for postsurgical remnants ablation and possible role of iodine content in L-thyroxine in the outcome of ablation.
    Barbaro D, Boni G, Meucci G, Simi U, Lapi P, Orsini P, Pasquini C, Piazza F, Caciagli M, Mariani G.
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4110-5. PubMed ID: 12970272
    [Abstract] [Full Text] [Related]

  • 17. Short-term effectiveness of low-dose radioiodune ablative treatment of thyroid remnants after thyroidectomy for differentiated thyroid cancer.
    Vermiglio F, Violi MA, Finocchiaro MD, Baldari S, Castagna MG, Moleti M, Mattina F, Pio Lo Presti V, Bonanno N, Trimarchi F.
    Thyroid; 1999 Apr; 9(4):387-91. PubMed ID: 10319946
    [Abstract] [Full Text] [Related]

  • 18. Thyroglobulin measurement before rhTSH-aided 131I ablation in detecting metastases from differentiated thyroid carcinoma.
    Giovanella L, Ceriani L, Suriano S, Ghelfo A, Maffioli M.
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):659-63. PubMed ID: 18363882
    [Abstract] [Full Text] [Related]

  • 19. Timing of post 131I ablation diagnostic whole body scan in differentiated thyroid cancer patients. Less than four months post ablation may be too early.
    Winter M, Winter J, Heinzel A, Behrendt FF, Krohn T, Mottaghy FM, Verburg FA.
    Nuklearmedizin; 2015 Oct; 54(4):151-7. PubMed ID: 26028188
    [Abstract] [Full Text] [Related]

  • 20. Outcome of differentiated thyroid cancer with detectable serum Tg and negative diagnostic (131)I whole body scan: comparison of patients treated with high (131)I activities versus untreated patients.
    Pacini F, Agate L, Elisei R, Capezzone M, Ceccarelli C, Lippi F, Molinaro E, Pinchera A.
    J Clin Endocrinol Metab; 2001 Sep; 86(9):4092-7. PubMed ID: 11549631
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.